FDA’s Announcement of the Approval of TRUMENBA^®

The FDA is announcing the approval of TRUMENBA<SUP>®</SUP>, the first vaccine approved in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.